Clinical trial
Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a…
NCT00343252 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00343252 |
|---|---|
| Title | Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis |
| Official title | The Effect of Teriparatide Compared With Risedronate on Back Pain in Postmenopausal Women With Osteoporotic Vertebral Fractures |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, Postmenopausal, Back Pain, Spinal Fracture |
| Intervention type | Drug |
| Interventions | teriparatide, risedronate, placebo |
| Enrollment | 712 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | Jun 22, 2006 |
| Last update posted | May 26, 2011 |
| Countries | Argentina, Australia, Belgium, Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain, Sweden and 1 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: